JMX0207, a niclosamide derivative with improved pharmacokinetics, suppresses Zika virus infection both in vitro and in vivo.
Li Z, Xu J, Lang Y, Fan X, Kuo L, D'Brant L, Hu S, Samrat S, Trudeau N, Tharappel A, et al. JMX0207, a niclosamide derivative with improved pharmacokinetics, suppresses Zika virus infection both in vitro and in vivo. ACS Infect Dis. 2020.